Takeda Pharmaceutical Company Limited (TAK)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 02:40PM EDT. Market open.
Show:
Annual
Income statement
Currency in JPY. All numbers in thousandsBreakdown
ttm
31/03/2023
31/03/2022
31/03/2021
Total revenue
4,169,049,000
4,027,478,000
3,569,006,000
3,197,812,000
Cost of revenue
1,353,949,000
1,244,072,000
1,106,846,000
994,308,000
Gross profit
2,815,100,000
2,783,406,000
2,462,160,000
2,203,504,000
Operating expenses
Research development
695,012,000
633,325,000
526,087,000
455,833,000
Selling general and administrative
1,023,381,000
997,309,000
886,361,000
875,663,000
Total operating expenses
2,439,793,000
2,230,300,000
1,928,585,000
1,805,437,000
Operating income or loss
375,307,000
553,106,000
533,575,000
398,067,000
Interest expense
162,871,000
116,973,000
122,432,000
130,806,000
Total other income/expenses net
-36,510,000
-42,374,000
-103,831,000
106,321,000
Income before tax
148,228,000
375,090,000
302,571,000
366,235,000
Income tax expense
-30,099,000
58,052,000
72,405,000
-9,936,000
Income from continuing operations
178,327,000
317,038,000
230,166,000
376,171,000
Net income
178,219,000
317,017,000
230,059,000
376,005,000
Net income available to common shareholders
178,219,000
317,017,000
230,059,000
376,005,000
Basic EPS
61.59
102.14
73.57
120.36
Diluted EPS
60.67
100.97
72.94
119.48
Basic average shares
3,114,752
3,103,618
3,127,002
3,124,012
Diluted average shares
3,152,861
3,139,744
3,154,338
3,147,074
© 2024 Yahoo. All rights reserved.